课题基金 / 基金详情

5-alpha reductase inhibitors and the prevention of prostate cancer

5-alpha reductase inhibitors and the prevention of prostate cancer
5-α还原酶抑制剂与前列腺癌的预防
批准号：
201371
负责人：
Azoulay Laurent
金额：
$14.63万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-03-01 至 2013-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=201371&lang=en
关键词：
5-Alpha Reductase Inhibitors Case-Control General Practice Research Database Prevention Prostate Cancer

项目摘要

项目成果

Azoulay Laurent的其他基金

相似基金

相关文献

中文摘要
翻译
前列腺癌仍然是男性中最常见的癌症。虽然多年来在治疗方面取得了重要进展，但最近的研究主要集中在可能预防其发生的药物治疗上。其中一项研究是
英文摘要
Prostate cancer remains the most frequently diagnosed cancer in men. While there were important advances in its treatment over the years, recent studies have focused on pharmacological therapies that may prevent its occurrence. One of such studies is the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study
Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations
The use of highly prolactin-elevating antipsychotics and the risk of ovarian and endometrial cancer
The use of beta-blockers and the prevention of cancer-specific mortality
海外基金